top of page
Anchor 1
Anchor 4
main
New studies with stem cell-derived islets for patients with T1DM
OPEN ENROLLMENT
-
for patients with T1DM and good kidney function
-
islets are infused in to the liver via a catheter
-
immunosupression medications are required
OPEN ENROLLMENT
VX24-880-102 Study (NEW study)
-
for patients with T1DM after kidney transplant
-
islets are infused in to the liver via a catheter
-
continue the same immunosupression medications
ENROLLMENT
CLOSE
-
devices containing islets will be surgically implanted behind the muscles of the abdomen
-
no immunosupression medication required
-
the study was terminated due to lack of effectiveness
bottom of page